Scleroderma Registry & Repository at the Hospital for Special Surgery
Recruiting
Observational Study
Scleroderma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Hospital for Special Surgery, New York · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Trial Locations
Loading…
Loading trial locations…
| Facility |
City |
State |
Country |
Status |
Eligibility Criteria
Inclusion Criteria:
* Individuals older than 18 years of age with Scleroderma
Exclusion Criteria:
* Individuals younger than 18 years of age
* Individuals older than 18 years of age without Scleroderma
Inclusion Criteria:
* Individuals older than 18 years of age with Scleroderma
Exclusion Criteria:
* Individuals younger than 18 years of age
* Individuals older than 18 years of age without Scleroderma